EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Topical imiquimod and in situ vulvar melanoma: A promising therapy?

Francesca Pepe iD, Flavia Silvestri, Eleonora Petra Preti, Anna Daniela Iacobone, Gianluigi Radici, Sabina Vaccari, Paola Queirolo, Giulio Tosti

International Journal of Gynecology & Obstetrics · 2025

DOI: 10.1002/ijgo.70087 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Francesca Pepe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dermato-Oncology Unit, European Institute of Oncology IRCCS, Milan, Italy. Hauptthemen laut MEDLINE: Aminoquinolines, Antineoplastic Agents, Melanoma, Vulvar Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Vulvar melanoma is a rare type of cancer that affects mainly postmenopausal women. There are no established protocols for the treatment of vulvar melanoma. From data extrapolated from the literature on cutaneous melanoma, surgical excision remains the best option for the resectable disease. Imiquimod, a topical immunomodulator, has been used in selected cases of in situ vulvar melanoma. Methods and Results We reported two cases of in situ vulvar melanoma treated with topical imiquimod 5%, either as first‐line therapy or adjuvant treatment, that showed a complete clinical response to topical treatment.

Conclusion

Imiquimod's beneficial and adverse effects in in situ vulvar melanoma treatment are examined.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AminoquinolinesAntineoplastic AgentsMelanomaVulvar NeoplasmsFemaleHumansAdministration, TopicalImiquimodTreatment Outcome

Stichwörter der Autor:innen

imiquimodin situ melanomatopical therapyvulvar diseasevulvar melanoma

Substanzen

AminoquinolinesAntineoplastic AgentsImiquimod

Autor:innen und Institutionen

  • Dermato-Oncology Unit, European Institute of Oncology IRCCS, Milan, Italy.
  • Preventive Gynecology Unit, European Institute of Oncology IRCCS, Milan, Italy.
  • Oncologic Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.
  • Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, European Institute of Oncology IRCCS, Milan, Italy.

ORCID-Profile: Francesca Pepe

Zitieren

APA

Pepe, F., Silvestri, F., Preti, E. P., Iacobone, A. D., Radici, G., Vaccari, S., Queirolo, P., & Tosti, G. (2025). Topical imiquimod and in situ vulvar melanoma: A promising therapy?. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70087

Vancouver

Pepe F, Silvestri F, Preti EP, Iacobone AD, Radici G, Vaccari S, et al. Topical imiquimod and in situ vulvar melanoma: A promising therapy?. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70087

BibTeX
@article{Pepe2025,
  author = {Pepe, Francesca and Silvestri, Flavia and Preti, Eleonora Petra and Iacobone, Anna Daniela and Radici, Gianluigi and Vaccari, Sabina and Queirolo, Paola and Tosti, Giulio},
  title = {Topical imiquimod and in situ vulvar melanoma: A promising therapy?},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2025},
  doi = {10.1002/ijgo.70087}
}
Kostenlos starten →